03 Mar 2017

ReproCELL Europe's CEO Dr David Bunton presented at NC3Rs workshop: Human tissue models for cancer research

ReproCELL Europe's CEO, Dr David Bunton presented at the recent NC3Rs meeting on the use of human tissues in cancer research. The conference considered the potential for human tissue models to help reduce clinical drug attrition and provide more relevant models of cancer using techniques such as 3D models, PDX systems and precision-cut tumour slices.

14 Feb 2017

ReproCELL Inc CEO meets with Scottish Cabinet Secretary Fiona Hyslop in Japan

ReproCELL Inc. (Japan)s CEO Dr Chikafumi Yokoyama had the honour of meeting with Fiona Hyslop, Cabinet Secretary for Culture, Tourism and External Affairs for the Scottish Government, during her visit to the Scottish Enterprise Tokyo office, today (14 February 2017).

07 Feb 2017

Scottish Enterprise Association Honours ReproCELL with Annual Awards Nomination

Scottish Enterprise Association Honours ReproCELL with Annual Awards Nomination

20 Jan 2017

Job vacancy: Clinical Alliances Manager

We wish to recruit a Clinical Alliances Manager to grow and manage our clinical network of hospitals, tissue banks and organ procurement organisations. The Clinical Alliances Manager ensures that sufficient donations of tissue are received to support ReproCELLs research on new medicines and to ensure compliance with relevant legal and regulatory requirements.

1 2 3 4 >>

Scottish Enterprise Association Honours ReproCELL with Annual Awards Nomination


Scotland’s Life Sciences Dinner was held on 2nd February 2017 at the National Museum of Scotland. The event was attended by CEO and Chairman of ReproCELL Inc, Dr Chikafumi Yokoyama, as well as senior management members of ReproCELL Europe Ltd, to join and celebrate the outstanding achievements of the Life Sciences sector in Scotland over the past year amongst over 800 guests.


Dr David Bunton, CEO of ReproCELL Europe Ltd, was one of the three finalist nominees at this year’s Life Science Business Leadership Award, which was part of Scotland’s Annual Life Science Awards and Dinner, 2017.


ABOVE: Banquet attendees from ReproCELL corporate and ReproCELL Europe are shown. From left: Professor Stefan Przyborski, (CSO ReproCELL Europe), Professor Bill Stimson, (Alfacyte), April Kelly, (Scottish Enterprise), Dr David Bunton (CEO ReproCELL Europe, Life Science Business Leader Award 2017 nominee), Dr Chikafumi Yokoyama, CEO of ReproCELL Corporate offices in Japan), Ed Hutchinson, (Scottish Enterprise), Dr Karen Bingham (COO, ReproCELL Europe), Daisuke Usui (CCO ReproCELL Europe).


Although not selected as the 2017 winner, Dr Bunton and ReproCELL Europe were honoured to be recognized as a finalist at the event. Our future plans are bold and aggressive, providing hope to compete again in the coming years.


It was our pleasure to participate in the event as a member of such a vibrant and active community of life science companies in Scotland, with world renowned researchers, clinical experts, and business managers.


ABOVE: The CEO of ReproCELL Inc (Japan), Dr Chikafumi Yokoyama, with Dolly the Sheep, exhibited at the National Museum of Scotland.


The Scottish Enterprise Association’s refreshed Life Sciences Strategy for Scotland – 2025 Vision was launched at the event, setting out the strategy to grow the already sizeable contribution that life sciences makes to the Scottish economy: the publication features researchers at ReproCELL’s human tissue lab in Glasgow (page 2). The strategy can be viewed at

Live chat by BoldChat